Paladin Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.71K Hold
13
﹤0.01% 225
2026
Q1
$4.57K Hold
13
﹤0.01% 222
2025
Q4
$4.25K Hold
13
﹤0.01% 228
2025
Q3
$3.67K Hold
13
﹤0.01% 222
2025
Q2
$3.63K Hold
13
﹤0.01% 223
2025
Q1
$4.05K Hold
13
﹤0.01% 216
2024
Q4
$3.39K Hold
13
﹤0.01% 222
2024
Q3
$4.19K Hold
13
﹤0.01% 221
2024
Q2
$4.04K Hold
13
﹤0.01% 211
2024
Q1
$3.68K Hold
13
﹤0.01% 211
2023
Q4
$3.74K Hold
13
﹤0.01% 211
2023
Q3
$3.49K Hold
13
﹤0.01% 235
2023
Q2
$2.89K Hold
13
﹤0.01% 249
2023
Q1
$3.14K Buy
+13
New +$3.19K ﹤0.01% 243
2022
Q2
Sell
-13
Closed -$3.19K 295
2022
Q1
$3K Buy
+13
New +$2.99K ﹤0.01% 258

Other funds holding AMGN

Paladin Advisory Group's AMGN Position: Q2 2026 in Review

Paladin Advisory Group held its Amgen (AMGN) position steady in Q2 2026 at 13 shares worth $4.71K. The position accounts for ﹤0.01% of the portfolio, ranked #225.

Paladin Advisory Group first reported a position in AMGN in Q1 2022 and has held it in 15 quarters since. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Paladin Advisory Group held 13 shares of Amgen worth $4.71K as of Q2 2026.
  • Paladin Advisory Group left its Amgen share count unchanged in Q2 2026.
  • Amgen made up ﹤0.01% of Paladin Advisory Group's portfolio in Q2 2026, its #225 holding.
  • Paladin Advisory Group first reported a position in Amgen in Q1 2022 and has held it in 15 quarters since.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Paladin Advisory Group's 13F filing for Q2 2026, filed 28 Jul 2026.